Avenue Supermarts Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: October 28, 2025, 1:32 pm

Competitors of Avenue Supermarts Ltd

All Competitor Stocks of Avenue Supermarts Ltd

Quarterly Result

Last Updated: August 1, 2025, 11:50 pm

Below is a detailed analysis of the quarterly data for Avenue Supermarts Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 16,360.00 Cr.. The value appears strong and on an upward trend. It has increased from 14,872.00 Cr. (Mar 2025) to 16,360.00 Cr., marking an increase of 1,488.00 Cr..
• For Expenses, as of Jun 2025, the value is 15,061.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 13,917.00 Cr. (Mar 2025) to 15,061.00 Cr., marking an increase of 1,144.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 1,299.00 Cr.. The value appears strong and on an upward trend. It has increased from 955.00 Cr. (Mar 2025) to 1,299.00 Cr., marking an increase of 344.00 Cr..
• For OPM %, as of Jun 2025, the value is 8.00%. The value appears strong and on an upward trend. It has increased from 6.00% (Mar 2025) to 8.00%, marking an increase of 2.00%.
• For Other Income, as of Jun 2025, the value is 19.00 Cr.. The value appears to be declining and may need further review. It has decreased from 25.00 Cr. (Mar 2025) to 19.00 Cr., marking a decrease of 6.00 Cr..
• For Interest, as of Jun 2025, the value is 29.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 19.00 Cr. (Mar 2025) to 29.00 Cr., marking an increase of 10.00 Cr..
• For Depreciation, as of Jun 2025, the value is 232.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 241.00 Cr. (Mar 2025) to 232.00 Cr., marking a decrease of 9.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 1,057.00 Cr.. The value appears strong and on an upward trend. It has increased from 720.00 Cr. (Mar 2025) to 1,057.00 Cr., marking an increase of 337.00 Cr..
• For Tax %, as of Jun 2025, the value is 27.00%. The value appears to be increasing, which may not be favorable. It has increased from 24.00% (Mar 2025) to 27.00%, marking an increase of 3.00%.
• For Net Profit, as of Jun 2025, the value is 773.00 Cr.. The value appears strong and on an upward trend. It has increased from 551.00 Cr. (Mar 2025) to 773.00 Cr., marking an increase of 222.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 11.88. The value appears strong and on an upward trend. It has increased from 8.47 (Mar 2025) to 11.88, marking an increase of 3.41.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 5:39 am

Growth

Last Updated: September 5, 2025, 12:05 am

Balance Sheet

Last Updated: July 25, 2025, 3:33 pm

Below is a detailed analysis of the balance sheet data for Avenue Supermarts Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 651.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 651.00 Cr..
• For Reserves, as of Mar 2025, the value is 20,777.00 Cr.. The value appears strong and on an upward trend. It has increased from 18,047.00 Cr. (Mar 2024) to 20,777.00 Cr., marking an increase of 2,730.00 Cr..
• For Borrowings, as of Mar 2025, the value is 820.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 592.00 Cr. (Mar 2024) to 820.00 Cr., marking an increase of 228.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 2,065.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,882.00 Cr. (Mar 2024) to 2,065.00 Cr., marking an increase of 183.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 24,313.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 21,172.00 Cr. (Mar 2024) to 24,313.00 Cr., marking an increase of 3,141.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 16,206.00 Cr.. The value appears strong and on an upward trend. It has increased from 13,415.00 Cr. (Mar 2024) to 16,206.00 Cr., marking an increase of 2,791.00 Cr..
• For CWIP, as of Mar 2025, the value is 1,099.00 Cr.. The value appears strong and on an upward trend. It has increased from 935.00 Cr. (Mar 2024) to 1,099.00 Cr., marking an increase of 164.00 Cr..
• For Investments, as of Mar 2025, the value is 3.00 Cr.. The value appears to be declining and may need further review. It has decreased from 107.00 Cr. (Mar 2024) to 3.00 Cr., marking a decrease of 104.00 Cr..
• For Other Assets, as of Mar 2025, the value is 7,004.00 Cr.. The value appears strong and on an upward trend. It has increased from 6,716.00 Cr. (Mar 2024) to 7,004.00 Cr., marking an increase of 288.00 Cr..
• For Total Assets, as of Mar 2025, the value is 24,313.00 Cr.. The value appears strong and on an upward trend. It has increased from 21,172.00 Cr. (Mar 2024) to 24,313.00 Cr., marking an increase of 3,141.00 Cr..

Notably, the Reserves (20,777.00 Cr.) exceed the Borrowings (820.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Avenue Supermarts Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 41.61. This value is within the healthy range. It has increased from 38.99 (Mar 24) to 41.61, marking an increase of 2.62.
• For Diluted EPS (Rs.), as of Mar 25, the value is 41.50. This value is within the healthy range. It has increased from 38.93 (Mar 24) to 41.50, marking an increase of 2.57.
• For Cash EPS (Rs.), as of Mar 25, the value is 54.97. This value is within the healthy range. It has increased from 50.20 (Mar 24) to 54.97, marking an increase of 4.77.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 329.29. It has increased from 287.34 (Mar 24) to 329.29, marking an increase of 41.95.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 329.29. It has increased from 287.34 (Mar 24) to 329.29, marking an increase of 41.95.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 912.18. It has increased from 780.49 (Mar 24) to 912.18, marking an increase of 131.69.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 70.87. This value is within the healthy range. It has increased from 65.31 (Mar 24) to 70.87, marking an increase of 5.56.
• For PBIT / Share (Rs.), as of Mar 25, the value is 57.51. This value is within the healthy range. It has increased from 54.08 (Mar 24) to 57.51, marking an increase of 3.43.
• For PBT / Share (Rs.), as of Mar 25, the value is 56.44. This value is within the healthy range. It has increased from 53.19 (Mar 24) to 56.44, marking an increase of 3.25.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 41.61. This value is within the healthy range. It has increased from 38.97 (Mar 24) to 41.61, marking an increase of 2.64.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 41.62. This value is within the healthy range. It has increased from 38.97 (Mar 24) to 41.62, marking an increase of 2.65.
• For PBDIT Margin (%), as of Mar 25, the value is 7.76. This value is below the healthy minimum of 10. It has decreased from 8.36 (Mar 24) to 7.76, marking a decrease of 0.60.
• For PBIT Margin (%), as of Mar 25, the value is 6.30. This value is below the healthy minimum of 10. It has decreased from 6.92 (Mar 24) to 6.30, marking a decrease of 0.62.
• For PBT Margin (%), as of Mar 25, the value is 6.18. This value is below the healthy minimum of 10. It has decreased from 6.81 (Mar 24) to 6.18, marking a decrease of 0.63.
• For Net Profit Margin (%), as of Mar 25, the value is 4.56. This value is below the healthy minimum of 5. It has decreased from 4.99 (Mar 24) to 4.56, marking a decrease of 0.43.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 4.56. This value is below the healthy minimum of 8. It has decreased from 4.99 (Mar 24) to 4.56, marking a decrease of 0.43.
• For Return on Networth / Equity (%), as of Mar 25, the value is 12.63. This value is below the healthy minimum of 15. It has decreased from 13.56 (Mar 24) to 12.63, marking a decrease of 0.93.
• For Return on Capital Employeed (%), as of Mar 25, the value is 16.92. This value is within the healthy range. It has decreased from 18.33 (Mar 24) to 16.92, marking a decrease of 1.41.
• For Return On Assets (%), as of Mar 25, the value is 11.13. This value is within the healthy range. It has decreased from 11.97 (Mar 24) to 11.13, marking a decrease of 0.84.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 2.61. It has increased from 2.59 (Mar 24) to 2.61, marking an increase of 0.02.
• For Current Ratio (X), as of Mar 25, the value is 2.89. This value is within the healthy range. It has decreased from 3.13 (Mar 24) to 2.89, marking a decrease of 0.24.
• For Quick Ratio (X), as of Mar 25, the value is 0.60. This value is below the healthy minimum of 1. It has decreased from 1.15 (Mar 24) to 0.60, marking a decrease of 0.55.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 13.23. This value exceeds the healthy maximum of 8. It has decreased from 14.17 (Mar 24) to 13.23, marking a decrease of 0.94.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 66.40. This value is within the healthy range. It has decreased from 73.12 (Mar 24) to 66.40, marking a decrease of 6.72.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 39.98. This value is within the healthy range. It has decreased from 44.62 (Mar 24) to 39.98, marking a decrease of 4.64.
• For Enterprise Value (Cr.), as of Mar 25, the value is 265,018.20. It has decreased from 294,099.73 (Mar 24) to 265,018.20, marking a decrease of 29,081.53.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 4.46. This value exceeds the healthy maximum of 3. It has decreased from 5.79 (Mar 24) to 4.46, marking a decrease of 1.33.
• For EV / EBITDA (X), as of Mar 25, the value is 57.47. This value exceeds the healthy maximum of 15. It has decreased from 69.20 (Mar 24) to 57.47, marking a decrease of 11.73.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 4.47. This value exceeds the healthy maximum of 3. It has decreased from 5.80 (Mar 24) to 4.47, marking a decrease of 1.33.
• For Price / BV (X), as of Mar 25, the value is 12.38. This value exceeds the healthy maximum of 3. It has decreased from 15.76 (Mar 24) to 12.38, marking a decrease of 3.38.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 4.47. This value exceeds the healthy maximum of 3. It has decreased from 5.80 (Mar 24) to 4.47, marking a decrease of 1.33.
• For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness